...O. Takamiya; S. Abe; A. Yoshioka; K. Nakajima; J.H. McVey; E.G.D. Tuddenham We report a factor VII (FVII) variant, FVII Shinjo , characterized by normal FVII antigen levels and variable procoagulant activity using tissue thromboplastin from different sources. Normal FVII activity is obtained using...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tissue factor Thromboplastin Monocytes Macrophages Differentiation...

...G. Baele; T. Fiers; G. Leroux-Roels Thrombotest® results expressed in international normalized ratio (INR) values, obtained in 108 patients on oral anticoagulant treatment, were compared with prothrombin time (PT) results with a recombinant thromboplastin. The former results were obtained...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tissue factor Thromboplastin...

... Tissue factor Thromboplastin Risk factors Heart disease Thrombosis M irinoslüsis S s s io n III: Extrinsic Coagulation Pathw ay and Disease Haemostasis 1996;26(suppl):66 71 James H. Morrissey Oklahoma Medical Research Foundation, Oklahoma City, Okla., USA Plasma Factor Vila: Measurement...

... was administered simultaneously with the endotoxin. This caused a suppression of the clearance of endotoxin from the circulation, and this in turn could probably account for some newly synthesized thromboplastin expressed by the circulating monocytes. Furthermore, monocyte activation appears to be significantly...

...Ma Xi; S. Béguin; H.C. Hemker We report a study on the importance of factor IX activation in thromboplastin-dependent coagulation in plasma. Diluted, CaCl 2 -containing thromboplastin solutions at constant phospholipid concentration were used to trigger the coagulation in plasma from patients...

...T.L. Janson; H. Stormorken; H. Prydz The species specificity of thromboplastin (tissue factor) is an important fact to take into consideration when clotting assays or experiments are planned. We have (re)investigated all possible combinations of thromboplastin and plasma from several of the most...

... in the induction of thromboplastin synthesis in blood monocytes and endothelial cells. © 1984 S. Karger AG, Basel 1984 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means...

...T. Lyberg Thromboplastin production in human monocytes gains steadily increasing significance as a pathogenetic factor in relation to human disease. A vast variety of stimuli can cause the induction of thromboplastin synthesis in monocytes, apparently through plasma membrane perturbation. Some...

... procoagulant substances, including thromboplastin, the potent trigger of the extrinsic pathway. Increasing evidence demonstrates the clinical importance of monocyte and macrophage thromboplastin synthesis in the pathogenesis of a variety of diseases. This review surveys the role of monocyte/macrophage...

...Roger T. Dean; Patricia Leoni; Bartira C. Rossi Mononuclear phagocytes can be activated to develop enhanced expression of a wide range of macromolecules and mediators. Amongst these are several procoagulants, most notably thromboplastin. A variety of stimuli (particles, ligands for cell surface...

..., Biomedical Center, Department o f Biochemistry, Maastricht, The Netherlands Key Words. Cellular procoagulant activity Thromboplastin Vitamin K dependent clotting factors Endotoxin stimulation Abstract. We developed a simple technique for the measurement of the procoagulant activ­ ity exposed...

... and CRM were found as compared to the reference and the group I values. No variations were found after vitamin K administration. Different thromboplastins, investigated with respect to their sensitivity for factor VII, acted differently. Patients with normal albumin levels also showed normal levels...